ITF Therapeutics LLC Presents Long-Term Data of DUVYZAT™ (givinostat) for Treatment of Duchenne Muscular Dystrophy at MDA Clinical and Scientific Conference
Seven abstracts highlight long-term effects, consistent safety profile, and delayed disease progression with givinostat